Jun J Yang Selected Research

Jun J Yang Research Topics

Disease

55	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2022 - 01/2009
19	Neoplasms (Cancer) 11/2022 - 01/2009
18	Leukemia 01/2022 - 01/2009
5	Residual Neoplasm 01/2021 - 01/2009
4	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2022 - 12/2019
3	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 01/2013
2	Neoplasm Metastasis (Metastasis) 11/2022 - 01/2018
2	Leukopenia 01/2021 - 01/2018
2	Drug-Related Side Effects and Adverse Reactions 01/2021 - 01/2017
2	Philadelphia Chromosome 01/2020 - 01/2018
2	Hearing Loss (Hearing Impairment) 04/2015 - 03/2015
1	Disease Progression 01/2022
1	Multiple Myeloma 01/2022
1	Infections 01/2022
1	Lymphoma (Lymphomas) 12/2021
1	Hypersensitivity (Allergy) 01/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	B-Cell Leukemia (Leukemia, B Cell) 11/2020
1	Glucocorticoid Receptor Deficiency 01/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 11/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Liver Neoplasms (Liver Cancer) 01/2018
1	Second Primary Neoplasms (Neoplasms, Second) 01/2018
1	Thiopurine S methyltranferase deficiency 08/2017
1	Autoimmune Diseases (Autoimmune Disease) 08/2017

Drug/Important Bio-Agent (IBA)

14	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 04/2022 - 04/2015
12	Pharmaceutical PreparationsIBA 01/2022 - 01/2009
10	2-mercaptopurineIBA 01/2022 - 06/2015
6	ChromatinIBA 01/2022 - 11/2019
5	RNA (Ribonucleic Acid)IBA 11/2022 - 03/2013
5	Asparaginase (Elspar)FDA Link 01/2022 - 01/2021
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2017
4	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2018
4	EnzymesIBA 01/2022 - 01/2017
4	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 03/2014
4	NucleotidesIBA 01/2021 - 04/2016
3	Dasatinib (BMS 354825)FDA Link 01/2022 - 01/2020
3	Transcription Factors (Transcription Factor)IBA 11/2021 - 01/2019
3	Thioguanine (Tioguanine)FDA Link 01/2021 - 01/2017
3	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2017
2	Histone Deacetylase InhibitorsIBA 01/2022 - 01/2017
2	Histones (Histone)IBA 01/2022 - 01/2017
2	Phosphotransferases (Kinase)IBA 12/2021 - 01/2018
2	venetoclaxIBA 01/2021 - 01/2020
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 01/2019
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 01/2021
2	AntimetabolitesIBA 01/2020 - 01/2020
2	thiopurine methyltransferase (thiopurine S-methyltransferase)IBA 01/2020 - 01/2013
2	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 01/2018
2	Cisplatin (Platino)FDA LinkGeneric 04/2015 - 03/2015
1	Amino Acids FDA Link 01/2022
1	IACS-010759IBA 01/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	GlutaminaseIBA 01/2022
1	Glutamine (L-Glutamine)FDA Link 01/2022
1	Sirtuin 1IBA 01/2022
1	ruxolitinibIBA 01/2022
1	CytokinesIBA 01/2022
1	PanobinostatIBA 01/2022
1	Janus KinasesIBA 12/2021
1	Proteolysis Targeting ChimeraIBA 12/2021
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 10/2021
1	AsparagineIBA 10/2021
1	Bendamustine Hydrochloride FDA Link 01/2021
1	pegaspargase (Oncaspar)FDA Link 01/2021
1	HLA-DQB1 antigen (HLA DQB1)IBA 01/2021
1	Clofarabine (Clolar)FDA Link 01/2021
1	AntigensIBA 01/2021
1	Biological FactorsIBA 01/2021
1	Etoposide (VP 16)FDA LinkGeneric 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021
1	NucleosidesIBA 01/2021
1	Vincristine (Oncovin)FDA LinkGeneric 01/2021
1	TransposasesIBA 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Drug CombinationsIBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	CD19-specific chimeric antigen receptorIBA 01/2020
1	ElementsIBA 12/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	Fluorouracil (Carac)FDA LinkGeneric 01/2019
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2018
1	Ikaros Transcription FactorIBA 01/2018
1	CHZ868IBA 01/2018
1	purine 5'-nucleotidaseIBA 01/2018

Therapy/Procedure

26	Therapeutics 03/2022 - 01/2009
9	Drug Therapy (Chemotherapy) 01/2022 - 01/2009
3	Cranial Irradiation 01/2021 - 12/2019
3	Remission Induction 01/2017 - 01/2009
2	Precision Medicine 11/2020 - 01/2020
2	Transplantation 01/2018 - 01/2013
1	Treatment Delay 01/2021
1	Intravenous Anesthesia 01/2021
1	Immunotherapy 01/2020
1	Heterologous Transplantation (Xenotransplantation) 01/2020
1	Adjuvant Chemotherapy 01/2019